10/14/2021
The National Institutes of Health (NIH) has named OMRF one of the lead sites for a nationwide Covid-19 vaccine clinical trial!
The study will assess the antibody response to an extra vaccine dose in people living with certain autoimmune diseases who did not respond well to an original Covid-19 vaccine regimen.
The study team will enroll approximately 600 participants at more than a dozen sites nationwide. The study will initially include people with one of five autoimmune diseases: multiple sclerosis, rheumatoid arthritis, pemphigus, systemic sclerosis or systemic lupus erythematosus.
Those who are interested in volunteering for the trial can get more information by calling OMRF at 405-271-7745.
OMRF was chosen because it is one of just 10 designated Autoimmunity Centers of Excellence in the U.S.